← Eichor
Study identifier: NCT07601932 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Patient Positioning for Treatment of Proximal Ureteral Stones

Condition: Ureteral Stone  ·  Sponsor: Icahn School of Medicine at Mount Sinai

PhaseNA
Planned participants54
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Ureteroscopic management of proximal ureteral stones presents technical challenges including stone retropulsion, prolonged operative time, and conversion to intrarenal treatment. Reverse Trendelenburg positioning has been shown to reduce proximal stone migration and operative time in ureteral stones, while the T-tilt position improves intrarenal stone clearance. The optimal strategy for proximal ureteral stones (treating stones in situ using reverse Trendelenburg versus pushing stones into the kidney followed by intrarenal treatment in T-tilt) remains unknown. This randomized controlled trial compares these two strategies, with primary focus on operative time as a measure of procedural efficiency. A total of 54 patients (27 per arm) will be enrolled at Mount Sinai West.

This description comes directly from the study's public registry record.

Talk to the study team

Mantu Gupta, MD  ·  212-241-1272  ·  mantu.gupta@mountsinai.org

Blair Gallante, MPH  ·  212-241-1272  ·  blair.gallante@mountsinai.org

Always discuss trial participation with your own doctor first.

Locations (1)

Mount Sinai WestNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07601932